Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	16.30	63.42	54.53
Graham Fair Price	2.29	2.13	2.08
PEG	297.07	-22.60	5.69
Price/Book	8.17	7.83	7.24
Price/Cash Flow	696.36	417.62	52.44
Prices/Earnings	18.24	40.68	34.40
Price/Sales	37.68	11.84	8.60
Price/FCF	696.36	417.62	52.44
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	13.18	0.19	0.17
Operating Margin	37.43	0.11	0.08
ROA	-2.39	0.02	0.02
ROE	0.05	0.05	-8.52
ROIC	0.03	0.03	16.18
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	-0.01	32.19
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.18	0.16	-12.07
EPS QOQ	0.06	-0.02	-70.22
FCF QOQ	2.19	-0.85	-61.00
Revenue QOQ	0.19	-0.16	-16.53
Naive Interpretation	member

03 - Financial Growth · Bad

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	21.31	24.30	13.99
Days Sales Outstanding (DSO)	27.67	26.50	-4.22
Inventory Turnover	4.22	3.70	-12.28
Debt/Capitalization	0.42	0.40	-4.36
Quick Ratio	0.84	0.83	-1.30
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	1.91	2.05	6.94
Cash	0.82	0.80	-2.31
Capex	-0.14	-0.14	-1.95
Free Cash Flow	0.26	0.04	-85.47
Revenue	1.61	1.35	-15.98
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.05	1.07	2.58
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	2.23	2.23	0.14
Naive Interpretation	Member

06 - Financial Health · Bad

Rating